Gunma University Heavy Ion Medical Center, Maebashi, Japan;
Department of Oral and Maxillofacial Surgery and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
Anticancer Res. 2022 Mar;42(3):1439-1446. doi: 10.21873/anticanres.15614.
BACKGROUND/AIM: Bone and soft-tissue sarcomas of the head and neck have very poor prognoses. This prospective study aimed to investigate the efficacy and safety of carbon-ion radiotherapy (C-ion RT) for bone and soft-tissue sarcoma of the head and neck.
The present study was a prospective clinical study that included 10 consecutive patients diagnosed with bone and soft-tissue sarcoma of the head and neck who were treated with C-ion RT between 2012 and 2018 at our institution. C-Ion RT consisted of 70.4 Gy (relative biological effectiveness) in 16 fractions.
The 3-year local control, overall survival, and progression-free survival rates for patients overall were 72.9%, 77.8%, and 36%, respectively.
The present study demonstrated the efficacy of C-ion RT for bone and soft-tissue sarcoma of the head and neck; adverse events were within the expected range.
背景/目的:头颈部的骨和软组织肉瘤预后极差。本前瞻性研究旨在探讨碳离子放疗(C-ion RT)对头颈部骨和软组织肉瘤的疗效和安全性。
本研究为前瞻性临床研究,纳入 2012 年至 2018 年间在我院接受 C-ion RT 治疗的 10 例连续诊断为头颈部骨和软组织肉瘤的患者。C-ion RT 采用 70.4 Gy(相对生物学效应),分 16 次进行。
患者的 3 年局部控制率、总生存率和无进展生存率分别为 72.9%、77.8%和 36%。
本研究表明 C-ion RT 对头颈部骨和软组织肉瘤有效,不良反应在预期范围内。